We are live on ! Find out more
Royal Bank of Canada

Royal Bank of Canada Portfolio holdings

AUM $672B
1-Year Est. Return 33.48%
 

Royal Bank of Canada (RBC), founded in 1864 and headquartered in Toronto, is Canada’s largest bank by market capitalization and one of the leading financial institutions in North America, offering a comprehensive suite of services including personal and commercial banking, wealth management, insurance, and capital markets. Managing hundreds of billions in assets, RBC serves millions of clients globally, with a significant presence in the U.S. and Caribbean through subsidiaries like RBC Wealth Management and City National Bank. Known for its stability and consistent profitability, RBC has earned a reputation as a conservative yet innovative bank, expanding its digital offerings and sustainability initiatives in recent years. With a strong focus on customer service and a robust international footprint, RBC remains a cornerstone of the Canadian and global financial systems.

This Fund
S&P 500
This Quarter Est. Return
+5.73%
1 Year Est. Return
+33.48%
3 Year Est. Return
+94.84%
5 Year Est. Return
+111.06%
10 Year Est. Return
+380.55%
AUM
$381B
AUM Growth
+$27.2B
Cap. Flow
+$10.3B
Cap. Flow %
2.7%
Top 10 Hldgs %
19.31%
Holding
8,037
New
676
Increased
3,797
Reduced
2,511
Closed
409

Sector Composition

Rank Sector Weight
1 Financials 18.63%
2 Technology 14.62%
3 Industrials 7.95%
4 Healthcare 7.93%
5 Energy 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCTX icon
6101
Lineage Cell Therapeutics
LCTX
$271M
$20K ﹤0.01%
14,234
+13,058
+1,110% +$18K
MMYT icon
6102
MakeMyTrip
MMYT
$5.68B
$20K ﹤0.01%
739
-1,081
-59% -$27.7K
NACP icon
6103
Impact Shares NAACP Minority Empowerment ETF
NACP
$77.8M
$20K ﹤0.01%
620
NAUT icon
6104
Nautilus Biotechnolgy
NAUT
$114M
$20K ﹤0.01%
5,277
+1,168
+28% +$3.37K
OVID icon
6105
Ovid Therapeutics
OVID
$528M
$20K ﹤0.01%
6,221
+6,164
+10,814% +$20.9K
PACK icon
6106
Ranpak Holdings
PACK
$478M
$20K ﹤0.01%
4,524
+1,848
+69% +$7.34K
QEMM icon
6107
State Street SPDR MSCI Emerging Markets StrategicFactors ETF
QEMM
$60.9M
$20K ﹤0.01%
357
-20
-5% -$1.11K
RIGL icon
6108
Rigel Pharmaceuticals
RIGL
$795M
$20K ﹤0.01%
1,618
-6,299
-80% -$85.2K
SEMR
6109
DELISTED
Semrush
SEMR
$20K ﹤0.01%
2,011
+1,882
+1,459% +$16.6K
SMTI icon
6110
Sanara MedTech
SMTI
$314M
$20K ﹤0.01%
+485
New +$19.8K
SRAD icon
6111
Sportradar
SRAD
$4.09B
$20K ﹤0.01%
1,540
+1,242
+417% +$15K
TFSL icon
6112
TFS Financial
TFSL
$4.95B
$20K ﹤0.01%
1,564
+225
+17% +$2.73K
TMQ
6113
Trilogy Metals
TMQ
$646M
$20K ﹤0.01%
34,052
+9,927
+41% +$5.6K
UROY
6114
Uranium Royalty Corp
UROY
$1.57B
$20K ﹤0.01%
9,922
+6,271
+172% +$12.5K
XFOR icon
6115
X4 Pharmaceuticals
XFOR
$418M
$20K ﹤0.01%
+341
New +$17.5K
UPGD icon
6116
Invesco Bloomberg Analyst Rating Improvers ETF
UPGD
$122M
$20K ﹤0.01%
336
-4
-1% -$221
GBNH
6117
DELISTED
Greenbrook TMS Inc. Common Shares
GBNH
$20K ﹤0.01%
31,030
-500
-2% -$339
THRX
6118
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$20K ﹤0.01%
2,112
+1,083
+105% +$10.7K
CRAK icon
6119
VanEck Oil Refiners ETF
CRAK
$273M
$19K ﹤0.01%
628
CTSO icon
6120
Cytosorbents Corp
CTSO
$25.1M
$19K ﹤0.01%
5,173
+2,637
+104% +$8.34K
CVRX icon
6121
CVRx
CVRX
$82.1M
$19K ﹤0.01%
1,172
+750
+178% +$9.15K
DAVE icon
6122
Dave Inc
DAVE
$4.27B
$19K ﹤0.01%
3,616
+2,633
+268% +$14.3K
ESEA icon
6123
Euroseas
ESEA
$521M
$19K ﹤0.01%
1,062
EYPT icon
6124
EyePoint Inc
EYPT
$1.27B
$19K ﹤0.01%
2,133
-2,327
-52% -$14.2K
GAA icon
6125
Cambria Global Asset Allocation ETF
GAA
$74.7M
$19K ﹤0.01%
706

Similar funds

Royal Bank of Canada's Q2 2023 Portfolio in Review

As of Q2 2023, Royal Bank of Canada held 8,037 positions worth $381B, up 7.7% from $354B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Royal Bank of Canada's Q2 2023 filing shows 676 new, 3,797 increased, 2,511 reduced and 409 closed positions. Its largest new stake was ATS Corp: 3,088,815 shares worth $142M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $815M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Royal Bank of Canada's largest Q2 2023 buy was ATS Corp: 3,088,815 shares worth $142M.
  • Royal Bank of Canada added most to Thermo Fisher Scientific in Q2 2023, an estimated $987M increase.
  • Royal Bank of Canada's biggest Q2 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $815M.
  • Royal Bank of Canada fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $150M.
  • Royal Bank of Canada's ten largest holdings make up 19% of its $381B portfolio in Q2 2023.
  • Royal Bank of Canada opened 676 new positions and closed 409 in Q2 2023.
  • Royal Bank of Canada's portfolio value rose 7.7% quarter-over-quarter to $381B.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.